Wave Life Sciences Stock Probability of Future Stock Price Finishing Under 14.21
| WVE Stock | USD 14.27 0.08 0.56% |
Wave |
Wave Life Target Price Odds to finish below 14.21
The tendency of Wave Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 14.21 or more in 90 days |
| 14.27 | 90 days | 14.21 | about 84.79 |
Based on a normal probability distribution, the odds of Wave Life to drop to $ 14.21 or more in 90 days from now is about 84.79 (This Wave Life Sciences probability density function shows the probability of Wave Stock to fall within a particular range of prices over 90 days) . Probability of Wave Life Sciences price to stay between $ 14.21 and its current price of $14.27 at the end of the 90-day period is near 1 .
Considering the 90-day investment horizon the stock has the beta coefficient of 3.73 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Wave Life will likely underperform. Moreover Wave Life Sciences has an alpha of 1.5278, implying that it can generate a 1.53 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Wave Life Price Density |
| Price |
Predictive Modules for Wave Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Wave Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Wave Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Wave Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Wave Life is not an exception. The market had few large corrections towards the Wave Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Wave Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Wave Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.53 | |
β | Beta against Dow Jones | 3.73 | |
σ | Overall volatility | 4.08 | |
Ir | Information ratio | 0.15 |
Wave Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Wave Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Wave Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M). | |
| Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 78.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Earnings call Rockwell Automation navigates tough year, eyes growth |
Wave Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Wave Stock often depends not only on the future outlook of the current and potential Wave Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Wave Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.1 M | |
| Cash And Short Term Investments | 200.4 M |
Wave Life Technical Analysis
Wave Life's future price can be derived by breaking down and analyzing its technical indicators over time. Wave Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Wave Life Sciences. In general, you should focus on analyzing Wave Stock price patterns and their correlations with different microeconomic environments and drivers.
Wave Life Predictive Forecast Models
Wave Life's time-series forecasting models is one of many Wave Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Wave Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Wave Life Sciences
Checking the ongoing alerts about Wave Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Wave Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M). | |
| Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 78.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Earnings call Rockwell Automation navigates tough year, eyes growth |
Check out Wave Life Backtesting, Wave Life Valuation, Wave Life Correlation, Wave Life Hype Analysis, Wave Life Volatility, Wave Life History as well as Wave Life Performance. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.11) | Return On Assets (0.34) | Return On Equity (2.44) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.